About Ventana
Ventana is a company based in Tucson (United States) founded in 1985 was acquired by Roche in June 2007. The company has 1,152 employees as of December 31, 2013. Ventana has completed 1 acquisition, including Spring Bioscience. Ventana operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Tucson, United States
- Employees 1152 as on 31 Dec, 2013
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ventana Medical Systems, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ventana
Unlock access to complete
Funding Insights of Ventana
Investors in Ventana
Ventana has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche and Point Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lease financing is provided to growth-stage companies in the US.
|
Locked | Locked | Locked | |
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Locked | Locked | Locked |
Investor details for Ventana
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ventana
Ventana has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Spring Bioscience.
Investment portfolio details for Ventana
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Immunohistochemistry (IHC) products with focus on monoclonal antibodies.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Ventana
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ventana
Detailed financials for Ventana
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ventana Comparisons
Peer comparison for Ventana
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ventana
Ventana operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of Ventana
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ventana
Complete news archive for Ventana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ventana
Ventana was founded in 1985 and raised its 1st funding round 27 years after it was founded.
Ventana is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.
As of Dec 31, 2013, the latest employee count at Ventana is 1,152.
Ventana Medical Systems, Inc. offers histology and pathology labs increased efficiency with automated HE, immunohistochemistry (IHC), in situ hybridization (ISH) stainers and workflow management solutions. Slide-based tissue diagnostics support diagnosis and inform cancer treatment decisions.
Ventana's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Ventana has made 1 acquisition, including Spring Bioscience.
Ventana has 2 investors. Key investors include Roche, and Point Financial.